Jonathan K. Embleton
Chief Business Officer
United States of America
Jonathan Embleton was appointed Chief Business Officer for Amerigen in 2010. Dr. Embleton has 20 years of experience in R&D, project management, business development, strategy and licensing, with a particular focus on drug delivery technologies and generic products. Prior to joining Amerigen, he served as the Vice President for Product Ventures at Catalent Pharma Solutions, where he was also a member of the Executive Leadership Team. Dr. Embleton was previously a vice-president working with generic pharmaceuticals for Cardinal Health, and earlier led the European business development and sales organization for Cardinal Health’s Pharmaceutical Technologies and Services business in Europe. Prior to that, Dr. Embleton held various product and technology development roles for RP Scherer Corporation.
Dr. Embleton earned a BSc in biochemistry and business administration, as well as a Ph.D in pharmaceutics, from the University of Aston in the UK.